Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
Identifieur interne : 004235 ( Main/Exploration ); précédent : 004234; suivant : 004236Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
Auteurs : Mary Lou Galantino [États-Unis] ; Krupali Desai ; Laurie Greene ; Angela Demichele ; Carrie Tompkins Stricker ; Jun James MaoSource :
- Integrative cancer therapies [ 1552-695X ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antinéoplasiques (effets indésirables), Antinéoplasiques (usage thérapeutique), Arthralgie (), Arthralgie (physiopathologie), Carcinomes (physiopathologie), Carcinomes (rééducation et réadaptation), Carcinomes (traitement médicamenteux), Femelle, Humains, Inhibiteurs de l'aromatase (effets indésirables), Inhibiteurs de l'aromatase (usage thérapeutique), Qualité de vie, Résultat thérapeutique, Sujet âgé, Survivants (), Tumeurs du sein (physiopathologie), Tumeurs du sein (rééducation et réadaptation), Tumeurs du sein (traitement médicamenteux), Yoga, Études de faisabilité.
- MESH :
- effets indésirables : Antinéoplasiques, Inhibiteurs de l'aromatase.
- physiopathologie : Arthralgie, Carcinomes, Tumeurs du sein.
- rééducation et réadaptation : Carcinomes, Tumeurs du sein.
- traitement médicamenteux : Carcinomes, Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques, Inhibiteurs de l'aromatase.
- Adulte d'âge moyen, Arthralgie, Femelle, Humains, Qualité de vie, Résultat thérapeutique, Sujet âgé, Survivants, Yoga, Études de faisabilité.
English descriptors
- KwdEn :
- Aged, Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Aromatase Inhibitors (adverse effects), Aromatase Inhibitors (therapeutic use), Arthralgia (chemically induced), Arthralgia (physiopathology), Arthralgia (therapy), Breast Neoplasms (drug therapy), Breast Neoplasms (physiopathology), Breast Neoplasms (rehabilitation), Carcinoma (drug therapy), Carcinoma (physiopathology), Carcinoma (rehabilitation), Feasibility Studies, Female, Humans, Middle Aged, Quality of Life, Survivors (statistics & numerical data), Treatment Outcome, Yoga.
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Aromatase Inhibitors.
- chemical , therapeutic use : Antineoplastic Agents, Aromatase Inhibitors.
- chemically induced : Arthralgia.
- drug therapy : Breast Neoplasms, Carcinoma.
- physiopathology : Arthralgia, Breast Neoplasms, Carcinoma.
- rehabilitation : Breast Neoplasms, Carcinoma.
- statistics & numerical data : Survivors.
- therapy : Arthralgia.
- Aged, Feasibility Studies, Female, Humans, Middle Aged, Quality of Life, Treatment Outcome, Yoga.
Abstract
Arthralgia affects postmenopausal breast cancer survivors (BCSs) receiving aromatase inhibitors (AIs). This study aims to establish the feasibility of studying the impact of yoga on objective functional outcomes, pain, and health-related quality of life (HR-QOL) for AI-associated arthralgia (AIAA). Postmenopausal women with stage I to III breast cancer who reported AIAA were enrolled in a single-arm pilot trial. A yoga program was provided twice a week for 8 weeks. The Functional Reach (FR) and Sit and Reach (SR) were evaluated as primary outcomes. Pain, as measured by the Brief Pain Inventory (BPI), self-reported Patient Specific Functional Scale (PSFS), and Functional Assessment of Cancer Therapy-Breast (FACT-B) were secondary outcomes. Paired t tests were used for analysis, and 90% provided data for assessment at the end of the intervention. Participants experienced significant improvement in balance, as measured by FR, and flexibility, as measured by SR. The PSFS improved from 4.55 to 7.21, and HR-QOL measured by FACT-B also improved; both P < .05. The score for the Pain Severity subscale of the BPI reduced. No adverse events nor development or worsening of lymphedema was observed. In all, 80% of participants adhered to the home program. Preliminary data suggest that yoga may reduce pain and improve balance and flexibility in BCSs with AIAA. A randomized controlled trial is needed to establish the definitive efficacy of yoga for objective functional improvement in BCSs related to AIAA.
DOI: 10.1177/1534735411413270
PubMed: 21733988
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002548
- to stream PubMed, to step Curation: 002548
- to stream PubMed, to step Checkpoint: 002548
- to stream Ncbi, to step Merge: 004504
- to stream Ncbi, to step Curation: 004504
- to stream Ncbi, to step Checkpoint: 004504
- to stream Main, to step Merge: 004251
- to stream Main, to step Curation: 004235
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.</title><author><name sortKey="Galantino, Mary Lou" sort="Galantino, Mary Lou" uniqKey="Galantino M" first="Mary Lou" last="Galantino">Mary Lou Galantino</name><affiliation wicri:level="2"><nlm:affiliation>The Richard Stockton College of New Jersey, Pomona, NJ 08240, USA. MaryLou.Galantino@Stockton.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Richard Stockton College of New Jersey, Pomona, NJ 08240</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Desai, Krupali" sort="Desai, Krupali" uniqKey="Desai K" first="Krupali" last="Desai">Krupali Desai</name></author><author><name sortKey="Greene, Laurie" sort="Greene, Laurie" uniqKey="Greene L" first="Laurie" last="Greene">Laurie Greene</name></author><author><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name></author><author><name sortKey="Stricker, Carrie Tompkins" sort="Stricker, Carrie Tompkins" uniqKey="Stricker C" first="Carrie Tompkins" last="Stricker">Carrie Tompkins Stricker</name></author><author><name sortKey="Mao, Jun James" sort="Mao, Jun James" uniqKey="Mao J" first="Jun James" last="Mao">Jun James Mao</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:21733988</idno><idno type="pmid">21733988</idno><idno type="doi">10.1177/1534735411413270</idno><idno type="wicri:Area/PubMed/Corpus">002548</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002548</idno><idno type="wicri:Area/PubMed/Curation">002548</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002548</idno><idno type="wicri:Area/PubMed/Checkpoint">002548</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002548</idno><idno type="wicri:Area/Ncbi/Merge">004504</idno><idno type="wicri:Area/Ncbi/Curation">004504</idno><idno type="wicri:Area/Ncbi/Checkpoint">004504</idno><idno type="wicri:Area/Main/Merge">004251</idno><idno type="wicri:Area/Main/Curation">004235</idno><idno type="wicri:Area/Main/Exploration">004235</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.</title><author><name sortKey="Galantino, Mary Lou" sort="Galantino, Mary Lou" uniqKey="Galantino M" first="Mary Lou" last="Galantino">Mary Lou Galantino</name><affiliation wicri:level="2"><nlm:affiliation>The Richard Stockton College of New Jersey, Pomona, NJ 08240, USA. MaryLou.Galantino@Stockton.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Richard Stockton College of New Jersey, Pomona, NJ 08240</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Desai, Krupali" sort="Desai, Krupali" uniqKey="Desai K" first="Krupali" last="Desai">Krupali Desai</name></author><author><name sortKey="Greene, Laurie" sort="Greene, Laurie" uniqKey="Greene L" first="Laurie" last="Greene">Laurie Greene</name></author><author><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name></author><author><name sortKey="Stricker, Carrie Tompkins" sort="Stricker, Carrie Tompkins" uniqKey="Stricker C" first="Carrie Tompkins" last="Stricker">Carrie Tompkins Stricker</name></author><author><name sortKey="Mao, Jun James" sort="Mao, Jun James" uniqKey="Mao J" first="Jun James" last="Mao">Jun James Mao</name></author></analytic><series><title level="j">Integrative cancer therapies</title><idno type="eISSN">1552-695X</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Aromatase Inhibitors (adverse effects)</term><term>Aromatase Inhibitors (therapeutic use)</term><term>Arthralgia (chemically induced)</term><term>Arthralgia (physiopathology)</term><term>Arthralgia (therapy)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (physiopathology)</term><term>Breast Neoplasms (rehabilitation)</term><term>Carcinoma (drug therapy)</term><term>Carcinoma (physiopathology)</term><term>Carcinoma (rehabilitation)</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Quality of Life</term><term>Survivors (statistics & numerical data)</term><term>Treatment Outcome</term><term>Yoga</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antinéoplasiques (effets indésirables)</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Arthralgie ()</term><term>Arthralgie (physiopathologie)</term><term>Carcinomes (physiopathologie)</term><term>Carcinomes (rééducation et réadaptation)</term><term>Carcinomes (traitement médicamenteux)</term><term>Femelle</term><term>Humains</term><term>Inhibiteurs de l'aromatase (effets indésirables)</term><term>Inhibiteurs de l'aromatase (usage thérapeutique)</term><term>Qualité de vie</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Survivants ()</term><term>Tumeurs du sein (physiopathologie)</term><term>Tumeurs du sein (rééducation et réadaptation)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Yoga</term><term>Études de faisabilité</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term><term>Aromatase Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term><term>Aromatase Inhibitors</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Arthralgia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Inhibiteurs de l'aromatase</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Arthralgie</term><term>Carcinomes</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arthralgia</term><term>Breast Neoplasms</term><term>Carcinoma</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Carcinomes</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Survivors</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Arthralgia</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinomes</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term><term>Inhibiteurs de l'aromatase</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Quality of Life</term><term>Treatment Outcome</term><term>Yoga</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Arthralgie</term><term>Femelle</term><term>Humains</term><term>Qualité de vie</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Survivants</term><term>Yoga</term><term>Études de faisabilité</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Arthralgia affects postmenopausal breast cancer survivors (BCSs) receiving aromatase inhibitors (AIs). This study aims to establish the feasibility of studying the impact of yoga on objective functional outcomes, pain, and health-related quality of life (HR-QOL) for AI-associated arthralgia (AIAA). Postmenopausal women with stage I to III breast cancer who reported AIAA were enrolled in a single-arm pilot trial. A yoga program was provided twice a week for 8 weeks. The Functional Reach (FR) and Sit and Reach (SR) were evaluated as primary outcomes. Pain, as measured by the Brief Pain Inventory (BPI), self-reported Patient Specific Functional Scale (PSFS), and Functional Assessment of Cancer Therapy-Breast (FACT-B) were secondary outcomes. Paired t tests were used for analysis, and 90% provided data for assessment at the end of the intervention. Participants experienced significant improvement in balance, as measured by FR, and flexibility, as measured by SR. The PSFS improved from 4.55 to 7.21, and HR-QOL measured by FACT-B also improved; both P < .05. The score for the Pain Severity subscale of the BPI reduced. No adverse events nor development or worsening of lymphedema was observed. In all, 80% of participants adhered to the home program. Preliminary data suggest that yoga may reduce pain and improve balance and flexibility in BCSs with AIAA. A randomized controlled trial is needed to establish the definitive efficacy of yoga for objective functional improvement in BCSs related to AIAA.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>New Jersey</li></region></list><tree><noCountry><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name><name sortKey="Desai, Krupali" sort="Desai, Krupali" uniqKey="Desai K" first="Krupali" last="Desai">Krupali Desai</name><name sortKey="Greene, Laurie" sort="Greene, Laurie" uniqKey="Greene L" first="Laurie" last="Greene">Laurie Greene</name><name sortKey="Mao, Jun James" sort="Mao, Jun James" uniqKey="Mao J" first="Jun James" last="Mao">Jun James Mao</name><name sortKey="Stricker, Carrie Tompkins" sort="Stricker, Carrie Tompkins" uniqKey="Stricker C" first="Carrie Tompkins" last="Stricker">Carrie Tompkins Stricker</name></noCountry><country name="États-Unis"><region name="New Jersey"><name sortKey="Galantino, Mary Lou" sort="Galantino, Mary Lou" uniqKey="Galantino M" first="Mary Lou" last="Galantino">Mary Lou Galantino</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004235 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004235 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21733988
|texte= Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21733988" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |